European Archives - Page 711 of 1225 - European Medical Journal

Boosting pharma sales rep’s virtual confidence

During the COVID-19 pandemic, pharmaceutical sales reps have been forced to navigate the virtual playing field, and as they operate in this new territory, their confidence is wavering.

Scientific Update from the Global Meeting of Experts in Dermatology (GMED 2020)

During this Global Meeting of Experts in Dermatology (GMED 2020 – winter edition, hosted by Greece colleagues) symposium, 8 experts of dermatology…

A Conversation on Diversity and Inclusion

We hear from three industry thought leaders who share their insights regarding the importance of championing diversity as well as their vision for pharma’s future.

The gender health gap

How can pharma better engage with male patients and encourage them to become more proactive when it comes to looking after their own health?

EMJ Oncology 8 [Supplement 4] 2020 Feature Image

3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant

More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…

EMJ Oncology 8 [Supplement 4] 2020 Feature Image

EMJ Oncology 8 [Supplement 4] 2020

The annual masterclass, organised by the Saudi Oncology Society (SOS), addressed the knowledge gaps in breast cancer care in Saudi Arabia…

Can Early Liver Damage Detection with a Novel Sensor Prevent Liver Failure?

FATTY liver disease is a condition experienced by one-quarter of the population in USA and, along with liver fibrosis, does not have a quick or easy…

Novel Predictive Model with Bedside Measures Predicts Hepatic Encephalopathy Risk

ACCURATE determination for the risk of and predictors for overt hepatic encephalopathy in patients with cirrhosis was measured using factors such as…

Lung Bacteria Can Defend Against Pneumonia

LACTOBACILLUS has been shown to provide a barrier against Streptococcus pneumoniae colonisation in mice infected with the influenza A virus, providing new insights on how bacteria protect against invading pathogens.

Could Targeting Endothelial Cells Diminish COVID-19 Symptoms?

TARGETING endothelial cells in patients with coronavirus disease (COVID-19) with severe lung disease may provide a novel approach to restoring normal lung function, according to a recent study from Stony Brook University, Stony Brook, New York, USA.